相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk A Nested Case-Control Study
Maria Trinidad Soria-Florido et al.
CIRCULATION (2020)
Tangier disease: update for 2020
Amanda J. Hooper et al.
CURRENT OPINION IN LIPIDOLOGY (2020)
Free cholesterol transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis underlies the U-shape relationship between HDL-cholesterol and cardiovascular disease
Ma Feng et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies
Guo-Chao Zhong et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
HDL subclasses and mortality in acute heart failure patients
Vesna Degoricija et al.
CLINICA CHIMICA ACTA (2019)
Association of extremely high levels of high-density lipoprotein cholesterol with endothelial dysfunction in men
Yuji Takaeko et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
CETP, LIPC, and SCARB1 variants in individuals with extremely high high-density lipoprotein-cholesterol levels
Chan Joo Lee et al.
SCIENTIFIC REPORTS (2019)
HDL subclass proteomic analysis and functional implication of protein dynamic change during HDL maturation
Yuling Zhang et al.
REDOX BIOLOGY (2019)
Association between high-density lipoprotein cholesterol and all-cause mortality in the general population of northern China
Xintao Li et al.
SCIENTIFIC REPORTS (2019)
Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study
Aya Hirata et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Examining the paradox of high high-density lipoprotein and elevated cardiovascular risk
Kavisha Singh et al.
JOURNAL OF THORACIC DISEASE (2018)
Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality inmen and women: two prospective cohort studies
Christian M. Madsen et al.
EUROPEAN HEART JOURNAL (2017)
Polygenic determinants in extremes of high-density lipoprotein cholesterol
Jacqueline S. Dron et al.
JOURNAL OF LIPID RESEARCH (2017)
High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis
Chengfeng Qiu et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Effects of Anacetrapib in Patients With Atherosclerotic Vascular Disease
L. Bowman et al.
JOURNAL OF VASCULAR SURGERY (2017)
HDL cholesterol: reappraisal of its clinical relevance
Winfried Maerz et al.
CLINICAL RESEARCH IN CARDIOLOGY (2017)
SR-B1 and PDZK1: partners in HDL regulation
Bernardo L. Trigatti
CURRENT OPINION IN LIPIDOLOGY (2017)
Dysfunctional HDL and atherosclerotic cardiovascular disease
Robert S. Rosenson et al.
NATURE REVIEWS CARDIOLOGY (2016)
Scavenger receptor B1 mutation, elevated HDL cholesterol and a paradoxical increase in atherosclerosis
Jillian Davidson et al.
CURRENT OPINION IN LIPIDOLOGY (2016)
The Relationship between Very High Levels of Serum High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in a 20-Year Follow-Up Study of Japanese General Population
Aya Hirata et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2016)
High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions The CANHEART Study
Dennis T. Ko et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism
Mengdie Luo et al.
LIPIDS IN HEALTH AND DISEASE (2016)
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease
Paolo Zanoni et al.
SCIENCE (2016)
Lymphocyte activation gene 3 and coronary artery disease
Diana Golden et al.
JCI INSIGHT (2016)
HDL particle subpopulations: Focus on biological function
Fabiana H. Rached et al.
BIOFACTORS (2015)
The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality
Nicole Pruefer et al.
BIOLOGICAL CHEMISTRY (2015)
Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content Correction by Sphingosine-1-Phosphate-Loading
Katherine Sattler et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
High-density lipoprotein synthesis and metabolism (Review)
Lingyan Zhou et al.
MOLECULAR MEDICINE REPORTS (2015)
Mendelian randomization of blood lipids for coronary heart disease
Michael V. Holmes et al.
EUROPEAN HEART JOURNAL (2015)
HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the lipoprotein investigators collaborative
Seth S. Martin et al.
EUROPEAN HEART JOURNAL (2015)
HDL in innate and adaptive immunity
Alberico Luigi Catapano et al.
CARDIOVASCULAR RESEARCH (2014)
HDL-Bound Sphingosine 1-Phosphate (S1P) Predicts the Severity of Coronary Artery Atherosclerosis
Katherine Sattler et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
High-Density Lipoprotein Vascular Protective Effects, Dysfunction, and Potential as Therapeutic Target
Thomas F. Luescher et al.
CIRCULATION RESEARCH (2014)
ATP-Binding Cassette Transporters, Atherosclerosis, and Inflammation
Marit Westerterp et al.
CIRCULATION RESEARCH (2014)
Mendelian Disorders of High-Density Lipoprotein Metabolism
Federico Oldoni et al.
CIRCULATION RESEARCH (2014)
HDL and cardiovascular disease
Daniel J. Rader et al.
LANCET (2014)
An abundant dysfunctional apolipoprotein A1 in human atheroma
Ying Huang et al.
NATURE MEDICINE (2014)
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
Jacy Crosby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
eNOS Activation by HDL Is Impaired in Genetic CETP Deficiency
Monica Gomaraschi et al.
PLOS ONE (2014)
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients
Daniel Keene et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Coronary Heart Disease Risks Associated with High Levels of HDL Cholesterol
John T. Wilkins et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Disease-associated marked hyperalphalipoproteinemia
Ken-Ichi Hirano et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2014)
Translation of High-Density Lipoprotein Function Into Clinical Practice Current Prospects and Future Challenges
Robert S. Rosenson et al.
CIRCULATION (2013)
Apolipoprotein AI and High-Density Lipoprotein Have Anti-Inflammatory Effects on Adipocytes via Cholesterol Transporters ATP-Binding Cassette A-1, ATP-Binding Cassette G-1, and Scavenger Receptor B-1
Tomio Umemoto et al.
CIRCULATION RESEARCH (2013)
Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting
Emiliano Angeloni et al.
EUROPEAN HEART JOURNAL (2013)
High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality
Guenther Silbernagel et al.
EUROPEAN HEART JOURNAL (2013)
High-density lipoproteins: A consensus statement from the National Lipid Association
Peter P. Toth et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2013)
The HDL proteome in acute coronary syndromes shifts to an inflammatory profile
Khalid Alwaili et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Cholesterol Efflux and Atheroprotection Advancing the Concept of Reverse Cholesterol Transport
Robert S. Rosenson et al.
CIRCULATION (2012)
HDL and Cardiovascular Risk Time to Call the Plumber?
Bernd Hewing et al.
CIRCULATION RESEARCH (2012)
Hepatic ABC transporters and triglyceride metabolism
John S. Parks et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease
Christian Besler et al.
EMBO MOLECULAR MEDICINE (2012)
Health benefits of high-density lipoproteins in preventing cardiovascular diseases
Hicham Berrougui et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
High-Density Lipoprotein Cholesterol and Particle Concentrations, Carotid Atherosclerosis, and Coronary Events MESA (Multi-Ethnic Study of Atherosclerosis)
Rachel H. Mackey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
Benjamin F. Voight et al.
LANCET (2012)
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Plasma lecithin: cholesterol acyltransferase and carotid intima-media thickness in European individuals at high cardiovascular risk
Laura Calabresi et al.
JOURNAL OF LIPID RESEARCH (2011)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
Christina Christoffersen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A synonymous variant in scavenger receptor, class B, type I gene is associated with lower SR-BI protein expression and function
Jason Constantineau et al.
ATHEROSCLEROSIS (2010)
A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome
Ron Waksman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans
Andrew C. Edmondson et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis
Daniel J. Rader et al.
JOURNAL OF LIPID RESEARCH (2009)
Lecithin: cholesterol acyltransferase - from biochemistry to role in cardiovascular disease
Xavier Rousset et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2009)
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
Esther M. M. Ooi et al.
CLINICAL SCIENCE (2008)
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: Significance for cardiovascular risk - The IDEAL and EPIC-Norfolk studies
Wim A. van der Steeg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
Toni I. Pollin et al.
SCIENCE (2008)
Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice
Christina Christoffersen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis -: A randomized controlled trial
Jean-Claude Tardif et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis
Anatol Kontush et al.
PHARMACOLOGICAL REVIEWS (2006)
New insights into the regulation of HDL metabolism and reverse cholesterol transport
GF Lewis et al.
CIRCULATION RESEARCH (2005)
Apolipoprotein M is required for preβ-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis
C Wolfrum et al.
NATURE MEDICINE (2005)
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3
JR Nofer et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
HDL deficiency and atherosclerosis: lessons from Tangier disease
GK Hovingh et al.
JOURNAL OF INTERNAL MEDICINE (2004)
A review of CETP and its relation to atherosclerosis
GJ de Grooth et al.
JOURNAL OF LIPID RESEARCH (2004)
A novel ApoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease
GK Hovingh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment
BJ Ansell et al.
CIRCULATION (2003)
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes - A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease
SM Boekholdt et al.
JOURNAL OF LIPID RESEARCH (2003)
Genetics of HDL regulation in humans
M Miller et al.
CURRENT OPINION IN LIPIDOLOGY (2003)
High-density lipoprotein subpopulations in pathologic conditions
BF Asztalos et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
HDL in atherosclerosis: actor or bystander?
BF Asztalos et al.
ATHEROSCLEROSIS SUPPLEMENTS (2003)
Cholesteryl ester transfer protein - A novel target for raising HDL and inhibiting atherosclerosis
PJ Barter et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement
JGN Garcia et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease
BF Asztalos et al.
ATHEROSCLEROSIS (2001)
Cubilin and megalin: Partners in lipoprotein and vitamin metabolism
JL Barth et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2001)
High-density lipoproteins protect endothelial cells from tumor necrosis factor-α-induced apoptosis
M Sugano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Structure and function of apolipoprotein A-I and high-density lipoprotein
JP Segrest et al.
CURRENT OPINION IN LIPIDOLOGY (2000)
分享论文
